CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Centene

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
100.1
Vs. acquisition
-2.6%
Brand index
100.1
Biosimilar index
101.4
Contract variability
Medium
Drugs observed
333
States
41

Contracts below the typical acquisition benchmark (102.7) on the median drug.

Thin book — treat these figures as indicative, not comparable.

How this payer prices

On this filing, the median drug carries 7 distinct contracted rates across practices, with 69% of billing volume on the single most common rate — a dispersed, negotiated book.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.